Skip to main content
. 2024 Sep 11;10(18):e37843. doi: 10.1016/j.heliyon.2024.e37843

Table 5.

Association of postoperative red blood cell transfusion volume with risk of the composite outcome in patients with preoperative anemia, stratified by perioperative hemoglobin decrease (ΔHb).

Patients with ΔHb <30 %
Units transfused (no. patients) Composite outcome n (%) Unadjusted odds ratio (95 % confidence interval) Adjusted odds ratioa (95 % confidence interval)
0.0 (467) 113 (24.2) 1 (reference) 1 (reference)
0.1–2.0 (187) 22 (11.8) 0.42 (0.26–0.68) 0.47 (0.27–0.82)
2.1–4.0 (104) 11 (10.6) 0.37 (0.19–0.72) 0.41 (0.20–0.84)
4.1–6.0 (52) 14 (26.9) 1.15 (0.60–2.21) 0.91 (0.43–1.95)
>6.0 (41) 19 (46.3) 2.71 (1.41–5.18) 1.99 (0.91–4.35)
P for trend

0.314
0.947
Patients with ΔHb ≥ 30 %
0.0 (n = 542)
191 (35.2)
1 (reference)
1 (reference)
0.1–2.0 (n = 174) 40 (23.0) 0.55 (0.37–0.81) 0.91 (0.58–1.41)
2.1–4.0 (n = 149) 35 (23.5) 0.56 (0.37–0.86) 0.71 (0.44–1.15)
4.1–6.0 (n = 83) 30 (36.1) 1.04 (0.64–1.68) 1.10 (0.64–1.91)
>6.0 (n = 71) 37 (52.1) 2.00 (1.22–3.29) 1.94 (1.08–3.50)
P for trend 0.137 0.102
a

Adjusted for sex, age (<65, ≥65 year), body mass index (<18.5, 18.5–24.9, 25.0–29.9 and ≥ 30.0 kg/m2), current smoking, ASA classification, comorbidities (see section 3.2 in main text), preoperative hemoglobin, postoperative nadir hemoglobin (<7.0, ≥7.0 g/dL), left ventricular function, type of surgery, cardiopulmonary bypass duration, and intraoperative red blood cell transfusion.